“Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s740. https://doi.org/10.25251/ztj3rn69.